According to Aidar Ishmukhametov, the center filed an application with the WHO for CoviVac’s assessment and its subsequent inclusion in the EUL in April 2021
Russia’s Chumakov Federal Scientific Center for the Research and Development of Immune and Biological Products of the Russian Academy of Sciences hopes to receive a license for the use of its CoviVac coronavirus vaccine in children in 2022
One of the main tasks of Russia’s academic leadership initiative is to give students the chance to realize their potential in ambitious research projects, even before they officially graduate.